Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FXRS7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,785.80 by the Defense Logistics Agency on August 12, 2025, with an ultimate completion date of August 13, 2025. The delivery order, issued under contract number 4569069910, is for NUCALA 100 MG/ML auto-injectors. This award was made without a set-aside designation, allowing the company to compete directly in the federal procurement market. The contract is performed at DMS Pharmaceutical Group's facility in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. The parent IDC enables the Defense Logistics Agency to procure a broad range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide, including prescription medications, biologics, over-the-counter medications, and specialty pharmaceutical items such as auto-injectors. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, providing critical medical products directly to military health facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FXRS7?
SPE2DB25FXRS7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FXRS7 worth?
The government has obligated $3,786 on SPE2DB25FXRS7.
Is contract SPE2DB25FXRS7 an order under another contract?
Yes. SPE2DB25FXRS7 is a delivery order under SPE2DB24D9131, an indefinite delivery contract.
Was contract SPE2DB25FXRS7 competed?
The extent of competition for SPE2DB25FXRS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award